DVA · 10-Q · 2026Q2 · Full report
Acquisitions and Divestitures
DAVITA INC. · 2026-08-04 · Importance 65 · Surprise 82 · In source text
Cash paid for acquisitions increased to $38.5 million in the first six months of 2026 from $10.6 million in the comparable 2025 period, a 263.7% year-over-year increase. Goodwill additions from acquisitions totaled $34.6 million, including $21.9 million in U.S. dialysis and $12.7 million in Other — Ancillary services. Goodwill increased to $7.591 billion at June 30, 2026 from $7.545 billion at December 31, 2025, including $11.3 million of foreign-currency and other adjustments. DaVita recorded no goodwill impairment charges during the six-month periods ended June 30, 2026 or 2025.
Key facts
- Acquisition expenditures for the six months ended June 30, 2026: $(39) million, an increase of $28 million vs prior period (254.5%) source
- Goodwill balance at June 30, 2026 by segment: U.S. dialysis $6,549,544; Other — Ancillary services $1,041,422; consolidated $7,590,966 source
- We have agreed to future investments in particular equity method and other investments if certain milestones are achieved or capital calls are made, as applicable. source
- We have potential obligations to purchase the noncontrolling interests held by third parties in many of our majority-owned dialysis partnerships and other nonconsolidated entities in the form of put provisions exercisable at the third-party owners’ discretion within specified periods. source
- The Company performed various annual impairment assessments during the six months ended June 30, 2026, with no impairment indicated and none of reporting units considered at risk of significant goodwill impairment as of June 30, 2026 source
- International operating income for Q2 2026 decreased vs Q1 2026 primarily driven by a loss on sale of divested centers source
- Proceeds from asset and business sales during six months ended June 30, 2026: $4,392 (compared to $22,400 in 2025) source
- Purchase of equity method investments during six months ended June 30, 2026: $19,625 source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -0.2% | Acquisition expenditures for the six months ended June 30, 2026: $(39) million, an increase of $28 million vs prior period (254.5%) |
| assets | positive | realized | — | Goodwill balance at June 30, 2026 by segment: U.S. dialysis $6,549,544; Other — Ancillary services $1,041,422; consolidated $7,590,966 |